Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-25-009168
Filing Date
2025-01-27
Accepted
2025-01-27 16:00:56
Documents
27
Period of Report
2025-03-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A enta-20250127.htm   iXBRL DEF 14A 3088382
2 GRAPHIC img217881502_0.jpg GRAPHIC 23222
3 GRAPHIC img217881502_1.jpg GRAPHIC 23222
4 GRAPHIC img217881502_2.jpg GRAPHIC 23222
5 GRAPHIC img217881502_3.jpg GRAPHIC 23222
6 GRAPHIC img217881502_4.jpg GRAPHIC 23222
7 GRAPHIC img217881502_5.jpg GRAPHIC 23222
8 GRAPHIC img217881502_6.jpg GRAPHIC 23222
9 GRAPHIC img217881502_7.jpg GRAPHIC 23222
10 GRAPHIC img217881502_8.jpg GRAPHIC 23222
11 GRAPHIC img217881502_9.jpg GRAPHIC 1147700
12 GRAPHIC img217881502_10.jpg GRAPHIC 1253854
13 GRAPHIC img217881502_11.jpg GRAPHIC 927684
14 GRAPHIC img217881502_12.jpg GRAPHIC 1407273
15 GRAPHIC img217881502_13.jpg GRAPHIC 208313
  Complete submission text file 0000950170-25-009168.txt   15908034

Data Files

Seq Description Document Type Size
16 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT enta-20250127.xsd EX-101.SCH 19230
29 EXTRACTED XBRL INSTANCE DOCUMENT enta-20250127_htm.xml XML 292964
Mailing Address 4 KINGSBURY AVENUE WATERTOWN MA 02472
Business Address 4 KINGSBURY AVENUE WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

EIN.: 043205099 | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-35839 | Film No.: 25558796
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)